[1]孙 融,周楚瑶,丁 媛,等.脓毒症患者血清生存素和沉默信息调节因子2 相关酶1 水平与其他血清炎症因子以及预后的关系研究[J].现代检验医学杂志,2022,37(04):81-86+91.[doi:10.3969/j.issn.1671-7414.2022.04.016]
　SUN Rong,ZHOU Chu-yao,DING Yuan,et al.Relationship between Serum Survivin and Silent Mating-type Information Regulation 2 Homologue 1 Levels and Other Serum Inflammatory Factors and Prognosis in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2022,37(04):81-86+91.[doi:10.3969/j.issn.1671-7414.2022.04.016]
点击复制

脓毒症患者血清生存素和沉默信息调节因子2 相关酶1 水平与其他血清炎症因子以及预后的关系研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年04期
页码:
81-86+91
栏目:
论著
出版日期:
2022-07-15

文章信息/Info

Title:
Relationship between Serum Survivin and Silent Mating-type Information Regulation 2 Homologue 1 Levels and Other Serum Inflammatory Factors and Prognosis in Patients with Sepsis
文章编号:
1671-7414（2022）04-081-07
作者:
孙 融; 周楚瑶; 丁 媛; 张 杰; 孙玲玲
东部战区总医院秦淮医疗区重症医学科，南京 210002
Author(s):
SUN Rong;  ZHOU Chu-yao;  DING Yuan;  ZHANG Jie;  SUN Ling-ling
Department of Critical Care, Qinhuai Medical District of Eastern Theater General Hospital, Nanjing 210002,China
关键词:
脓毒症; 生存素; 沉默信息调节因子2 相关酶1
分类号:
R631；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.04.016
文献标志码:
A
摘要:
目的 研究脓毒症患者血清生存素（survivin）、沉默信息调节因子2 相关酶1（silent mating-type informationregulation 2 homologue 1，SIRT1）水平与其他血清炎症因子以及预后的关系。方法 纳入2018 年9 月～ 2021 年2 月东部战区总医院收治的脓毒症患者130 例（脓毒症组），另选取同期体检的健康志愿者65 例（对照组）。比较两组血清survivin，SIRT1，白细胞介素-1β（interleukin-1β，IL-1β）、白细胞介素-6（interleukin 6，IL-6）、肿瘤坏死因子-α（tumor necrosis factor-α，TNF-α）、C 反应蛋白（C-reactive protein ，CRP）和降钙素原（procalcitonin ，PCT）水平。根据住院期间预后分为生存组（n=92）、死亡组（n=38），分析血清survivin 和SIRT1 与炎症因子及急性生理和慢性健康状况评分系统Ⅱ（acute physiology and chronic health evaluation Ⅱ，APACHE Ⅱ）、序贯器官功能衰竭（sequentialorgan failure assessment ，SOFA）评分的相关性，绘制受试者工作特征曲线（receiver operating characteristic curve ，ROC）分析血清survivin 和SIRT1 评估预后的曲线下面积（area under the curve ，AUC）。结果 脓毒症组血清survivin（423.04±98.65pg/ml） 和SIRT1（0.59±0.11ng/ml） 水平低于对照组（876.43±124.71 pg/ml,1.95±0.43ng/ml）， 血清IL-1β（13.55±3.21pg/ml），IL-6（71.56±18.67 pg/ml），TNF-α（121.18±23.75 pg/ml），CRP（19.23±2.36mg/dl）和PCT（6.72±1.29ng/ml）水平高于对照组（3.41±0.86pg/ml, 5.32±1.22 pg/ml, 5.93±1.18 pg/ml，4.25±0.99 mg/dl，2.31±0.25 ng/ml），差异均有统计学意义（t=25.092 ～ 62.243，均P =0.000）。脓毒症患者生存组血清survivin（435.66±49.75pg/ml）和SIRT1（0.63±0.12ng/ml）水平高于死亡组（392.47±53.35 pg/ml, 10.48±0.10ng/ml），而血清IL-1β（12.14±2.10pg/ml），IL-6（69.63±10.07 pg/ml），TNF-α（116.20±9.13 pg/ml），CRP（18.69±1.82 mg/dl）和PCT（6.33±0.68 ng/ml）水平及APACHEⅡ（13.25±2.64 分）和SOFA评分（5.42±1.20 分）低于死亡组（16.98±1.02pg/ml，76.23±7.64pg/ml，133.23±8.95pg/ml，20.54±1.05mg/dl，7.65±0.36ng/ml，15.88±2.69 分，6.77±1.16 分），差异均有统计学意义（t=3.629 ～ 17.636，均P=0.000）。Pearson 线性相关分析显示血清survivin 和SIRT1 与血清IL-1β，IL-6，TNF-α，CRP 和PCT 水平及APACHE Ⅱ，SOFA 评分呈负相关（r =-0.584 ～ -0.347，均P ＜ 0.05）。血清survivin 和SIRT1 单独与联合评估脓毒症患者预后的AUC（0.95CI）分别为0.710（0.95CI 0.466 ～ 0.957），0.756（0.95CI0.540 ～ 0.965）和0.833（0.95CI 0.740 ～ 0.927）。结论 脓毒症患者血清survivin 和SIRT1 水平降低，二者与促炎因子呈负相关，有望成为预测预后的指标。
Abstract:
Objective To study the relationship between serum survivin (survivin), silent mating type information regulation 2 homologue 1 (SIRT1) levels and other serum inflammatory factors and prognosis in patients with sepsis. Methods Patients with sepsis (sepsis group, n=130) who were admitted to Eastern Theater General Hospital from September 2018 to February 2021 were included. In addition, healthy volunteers (control group, n=65) were selected. The two groups of serum survivin, SIRT1, interleukin-1β (IL-1β), interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP), procalcitonin (PCT) levels were compared. According to the prognosis of patients during hospitalization, they were divided into survival group (n=92) and death group (n=38). The correlation between serum survivin, SIRT1, inflammatory factors, acute physiology and chronic health evaluation Ⅱ (APACHEⅡ ), sequential organ failure assessment (SOFA) were analyzed. The receiver operating characteristic curve (ROC) was drawn to analyze the area under the curve (AUC) of serum survivin and SIRT1 to assess the prognosis. Results The levels of serum survivin （423.04±98.65pg/ml）and SIRT1（0.59±0.11ng/ml） in the sepsis group were lower than those in the control group（876.43±124.71 pg/ml,1.95±0.43ng/ml），and the levels of serum IL-1β（13.55±3.21pg/ ml），IL-6（71.56±18.67 pg/ml）, TNF-α（121.18±23.75 pg/ml）, CRP（19.23±2.36mg/dl） and PCT （6.72±1.29ng/ ml）were higher than those in the control group（3.41±0.86pg/ml, 5.32±1.22 pg/ml, 5.93±1.18 pg/ml，4.25±0.99 mg/dl， 2.31±0.25 ng/ml），the differences were statistically significant(t=25.092 ～ 62.243, all P=0.000). The levels of serum survivin （435.66±49.75pg/ml）and SIRT1（0.63±0.12ng/ml） in the survival group of patients with sepsis were higher than those in the death group（392.47±53.35 pg/ml, 10.48±0.10ng/ml）, while the serum levels of IL-1β（12.14±2.10pg/ml ）, IL-6 （69.63±10.07 pg/ml）, TNF-α（116.20±9.13 pg/ml）, CRP（18.69±1.82 mg/dl）, PCT（6.33±0.68 ng/ml） and APACHE Ⅱ（13.25±2.64 point）, SOFA（5.42±1.20 point） scores were lower than those in the death group （16.98±1.02pg/ ml，76.23±7.64pg/ml，133.23±8.95pg/ml，20.54±1.05mg/dl，7.65±0.36ng/ml，15.88±2.69 point， 6.77±1.16 point）, the differences were statistically significant（t=3.629 ～ 17.636，all P=0.000）. Pearson linear correlation analysis showed that serum survivin and SIRT1 were negatively correlated with serum IL-1β, IL-6, TNF-α, CRP, PCT levels and APACHE Ⅱ , SOFA scores (r=-0.584 ～ -0.347, all P ＜ 0.05). The AUC (0.95CI) of serum survivin and SIRT1 alone and in combination to assess the prognosis of patients with sepsis were 0.710 (0.95CI 0.466 ～ 0.957), 0.756 (0.95CI 0.540 ～ 0.965) and 0.833 (0.95CI 0.740 ～ 0.927), respectively. Conclusion The levels of serum survivin and SIRT1 in patients with sepsis were reduced, and the two were negatively correlated with pro inflammatory factors, which are expected to be indicators of prognosis.

参考文献/References:

[1] 沈丽娟, 孙杰, 吴晓, 等．老年脓毒症患者血清清蛋白水平与其危重程度及预后的相关性[J]. 现代检验医学杂志, 2017, 32（1）：131-133, 137． SHEN Lijuan, SUN Jie, WU Xiao, et al. Relationship of albumin levels with the prognosis and severity of illness among elderly sepsis patients[J]. Journal of Modern Laboratory Medicine,2017, 32(1):131-133, 137.
[2] VINCENT J L, OPAL S M, MARSHALL J C, et al.Sepsis definitions: time for change[J]. Lancet, 2013,381(9868): 774-775.
[3] CHOUSTERMAN B G, SWIRSKI F K, WEBER G F. Cytokine storm and sepsis disease pathogenesis[J].Seminars in Immunopathology, 2017, 39(5): 517-528.
[4] 张春侠, 蔡盈, 丁可, 等.4 种评分系统对脓毒症患儿预后的预测价值[J]. 临床急诊杂志, 2020, 21 (12):991-995． ZHANG Chunxia, CAI Ying, DING Ke, et al.Prognostic value of four scoring systems in children with sepsis [J]. Journal of Clinical Emergency, 2020,21(12):991-995.
[5] 金玲, 丁丽娜, 于烁, 等. 凋亡蛋白抑制因子Survivin 的研究进展[J]. 中国实验诊断学, 2018, 22(6): 1100-1102. JIN Ling, DING Lina, YU Shuo, et al. Research progress of apoptosis protein inhibitor Survivin [J].Chinese Journal of Laboratory Diagnosis, 2018, 22(6):1100-1102.
[6] 陈林林, 刘云涛, 吴娇, 等.SIRT1 在肾纤维化中的作用及机制[J]. 生命的化学, 2020, 40(11):1994-1999. CHEN Linlin, LIU Yuntao, WU Jiao, et al. The role and mechanism of SIRT1 in renal fibrosis [J]. Chemistry of Life, 2020, 40(11):1991-1999.
[7] SINGER M, DEUTSCHMAN C S, SEYMOUR C W,et al. The third international consensus definitions for sepsis and septic shock (sepsis 3)[J]. the Journal of the American Medical Association, 2016, 315(8): 801-810.
[8] KNAUS W A, ZIMMERMAN J E, WAGNER D P,et al. APACH E-acute physiology and chronic health evaluation: a physiologically based classification system[J]. Critical Care Medicine, 1981, 9(8): 591-597.
[9] TALLGREN M, B?CKLUND M, HYNNINEN M. Accuracy of sequential organ failure assessment (SOFA) scoring in clinical practice[J]. Acta Anaesthesiologica Scandinavica, 2009, 53(1): 39-45.
[10] MIRA J C, GENTILE L F, MATHIAS B J, et al. Sepsis pathophysiology,chronic critical illness,and persistent inflammation-immunosuppression and catabolism syndrome[J]. Critical Care Medicine, 2017, 45(2): 253-262.
[11] SANKOFF J D, GOYAL M, GAIESKI D F, et al.Validation of the mortality in emergency department sepsis (MEDS) score in patients with the systemic inflammatory response syndrome (SIRS)[J]. Critical Care Medicine, 2008, 36(2): 421-426.
[12] 夏文芳, 李冰玉, 林维山, 等. 脓毒症的治疗进展[J].医学综述, 2019, 25(11):2169-2175. XIA Wenfang, LI Bingyu, LIN Weishan, et al. Progress in treatment of sepsis [J]. Medical Recapitulate, 2019,25（11）:2169-2175.
[13] MARTINI E, SCHNEIDER E, NEUFERT C, et al.Survivin is a guardian of the intestinal stem cell niche and its expression is regulated by TGF β[J]. Cell Cycle(Georgetown, Tex.), 2016, 15(21): 2875-2881.
[14] 郑超, 田作春, 苏永超, 等.SIRT1 信号通路介导葛根素抵抗脓毒症心肌损伤的机制研究[J]. 山西医科大学学报, 2020, 51(1):46-52. ZHENG Chao, TIAN Zuochun, SU Yongchao, et al.Study on the mechanisms of the protective effects of puerarin against sepsis-induced myocardial injury by the SIRT1 signaling pathway [J]. Journal of Shanxi Medical University, 2020, 51（1）:46-52.
[15] 陈菊华, 王一理, 张宏伟. 大肠癌组织中Survivin，MSH2，MSH6 表达及其临床意义[J]. 中国医师杂志,2020, 22(2): 228-232. CHEN Juhua, WANG Yili, ZHANG Hongwei.Expression and its clinicopathological significance of Survivin,MSH2 and MSH6 in colorectal cancer [J].Journal of Chinese Physician , 2020, 22(2):228-232.
[16] 怡萍, 徐启英, 郭新建.Survivin 和Smac/Diab 介导的细胞凋亡信号通路与胎膜早破的相关性[J]. 广东医学, 2016, 37(22):3434-3436. YI Ping, XU Qiying, GUO Xinjian. The correlation between the apoptosis signal pathway mediated by Survivin and Smac/Diab and premature rupture of membranes[J]. Guangdong Medical Journal, 2016,37(22):3434-3436.
[17] MILIARAKI M, BRIASSOULIS P, ILIA S, et al.Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis[J]. Scientific Reports, 2021, 11(1): 1049.
[18] 邓建平, 罗和国, 焦守峰, 等．SIRT1 信号通路在大鼠内毒素性急性肺损伤中的作用[J]. 中华麻醉学杂志, 2019, 39(2):243-246. DENG Jianping, LUO Heguo, JIAO Shoufeng, et al. Role of SIRT1 signaling pathway in endotoxininduced acute lung injury in rats [J]. Chinese Journal of Anesthesilolgy, 2019, 39（2）:243-246.
[19] 曹小洁, 张明杰, 张莉莉, 等．SIRT1 通过抑制NF κB 信号通路而抑制oxLDL 诱导的VSMC 源性泡沫细胞形成[J]. 四川医学, 2019, 40(5):449-453. CAO Xiaojie, ZHANG Mingjie, ZHANG Lili, et al.SIRT1 inhibits ox LDL-induced VSMC-derived foam cell formation by inhibiting NF-κB signaling pathway[J]. Sichuan Medical Journal ,2019,40(5):449-453.
[20] 王秋云, 陈影, 赵冰, 等．Sirt1 通过HNF 1α/FXR 1通路调控脓毒症肝损伤的动物研究[J]. 诊断学理论与实践, 2020, 19(3):279-285． WANG Qiuyun, CHEN Ying, ZHAO Bing, et al.Sirt1 involved in sepsis-induced acute liver injury via regulating HNF-1α/FXR-1 pathway:The mechanism study in a rodent model [J]. Journal of Diagnostics Concepts & Practice,2020,19(3):279-285.
[21] 黄林枫, 熊岚, 吴奎, 等．脓毒症患儿血浆miR-146a, miR-223 表达与IL-6, IL-10, TNF-α 水平变化的临床意义分析[J]. 现代生物医学进展, 2017, 17(32):6324-6327, 6344. HUANG Linfeng, XIONG Lan, WU Kui, et al.Analysis of the clinical significances of plasma miR-146a,miR-223,IL-10,TNF-α and IL-6 levels in children with sepsis [J]. Progress in Modern Biomedicine,2017,17(32):6324-6327,6344.
[22] 罗兰, 曾方玲, 隆彩霞, 等．脓毒症患儿心功能与血清TNF-α，IL-1β 水平的相关性分析[J]. 中国医药导报, 2020, 17(30):16-19, 23. LUO Lan, ZENG Fangling, LONG Caixia, et al.Correlation analysis of heart function and serum TNF-α, IL-1β levels in children with sepsis [J].China Medical Herald, 2020, 17(30):16-19, 23.
[23] 孟小征, 马怀安, 乔博明, 等.T 淋巴细胞、炎性因子及心肌酶对脓毒症严重程度的评估价值研究[J].临床误诊误治, 2019, 32(1):75-79. MENG Xiaozheng, MA Huaian, QIAO Boming, et al. The value of T lymphocytes,inflammatory factors and myocardial enzymes in assessing the severity of sepsis [J]. Clinical Misdiagnosis & Mistherapy, 2019,32(1):75-79.
[24] 魏明豪, 曹屹东, 贾栋, 等．和厚朴酚通过激活SIRT1/FOXO1 信号通路抵抗小鼠脓毒症脑损伤[J].现代生物医学进展, 2019, 19(10)：1840-1844. WEI Minghao, CAO Yidong, JIA Dong, et al. Honokiol alleviates brain injury in septic mice through activating SIRT1/FOXO1 signaling [J]. Progress in Modern Biomedicine,2019,19(10):1840-1844.
[25] 曹佳, 杨华英, 何艺, 等．姜黄素通过激活SIRT1 调节脓毒症小鼠模型的认知功能障碍研究[J]．陕西中医, 2020, 41(3):301-307． CAO Jia, YANG Huaying, HE Yi, et al. Curcumin regulates cognitive dysfunction in sepsis mice by activating SIRT1 [J]. Shaanxi Journal of Traditional Chinese Medicine, 2020, 41(3):301-307.
[26] 潘日虹．早期cTnI, PCT, CRP 对脓毒血症患者预后的影响[J]．临床急诊杂志, 2018, 19(5):338-341． PAN Rihong. The effect of early stage of cTnI,CRP and PCT on prognosis of sepsis patients [J]. Journal of Clinical Emergency, 2018, 19(5)338-341.

相似文献/References:

[1]沈丽娟a,孙 杰a,吴 晓b,等.老年脓毒症患者血清清蛋白水平与其危重程度及预后的相关性[J].现代检验医学杂志,2017,32(01):131.[doi:10.3969/j.issn.1671-7414.2017.01.036]
　SHEN Li-juana,SUN Jiea,WU Xiaob,et al.Relationship of Albumin Levels with the Prognosis and Severity of Illness among Elderly Sepsis Patients[J].Journal of Modern Laboratory Medicine,2017,32(04):131.[doi:10.3969/j.issn.1671-7414.2017.01.036]
[2]佟 丽,黄丽萍,石晓霞,等.血栓弹力图检测新型冠状病毒肺炎患者凝血功能的探讨分析[J].现代检验医学杂志,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
　TONG Li,HUANG Li-ping,SHI Xiao-xia,et al.Investigation and Analysis of Thromboelastography in the Detection of COVID-19 Patients[J].Journal of Modern Laboratory Medicine,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
[3]肖武强,徐敏丹,吴先正.脓毒症患者血清肠型脂肪酸结合蛋白、二胺氧化酶水平检测对早期肠组织损伤及预后的评估价值[J].现代检验医学杂志,2021,36(01):10.[doi:10.3969/j.issn.1671-7414.2021.01.003]
　XIAO Wu-qiang,XU Min-dan,WU Xian-zheng.Evaluation Value of Serum Intestinal Fatty Acid Binding Protein and Diamine Oxidase in the Early Stage of Intestinal Tissue Injury and Prognosis in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(04):10.[doi:10.3969/j.issn.1671-7414.2021.01.003]
[4]张　晨,孙虹佳.新型感染标志物在脓毒症早期诊断中的应用及研究进展[J].现代检验医学杂志,2021,36(01):156.[doi:10.3969/j.issn.1671-7414.2021.01.038]
　ZHANG Chen,SUN Hong-jia.Latest Research Progress of Early Serum Inflammatory and Oxidative Stress Mediator of Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(04):156.[doi:10.3969/j.issn.1671-7414.2021.01.038]
[5]张　珍,王新庄.脓毒症患者血清 YKL-40 水平检测与急性肾损伤早期诊断的相关性研究[J].现代检验医学杂志,2021,36(03):148.[doi:10.3969/j.issn.1671-7414.2021.03.034]
　ZHANG Zhen,WANG Xin-zhuang.Correlation between Serum YKL-40 Level and Early Diagnosis of AcuteKidney Injury in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(04):148.[doi:10.3969/j.issn.1671-7414.2021.03.034]
[6]王　海,肖　华,陈兴壮.血浆miR-223-3p，PCT，IL-6和CRP水平联合检测对脓毒症实验诊断及预后的价值研究[J].现代检验医学杂志,2021,36(05):51.[doi:10.3969/j.issn.1671-7414.2021.05.011]
　WANG Hai,XIAO Hua,CHEN Xing-zhuang.Value of Combined Detection of Plasma miR-223-3p, PCT, IL-6 and CRPLevels in Experimental Diagnosis and Prognosis of Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(04):51.[doi:10.3969/j.issn.1671-7414.2021.05.011]
[7]洪　莉,郑　青,陈永香,等.脓毒症并发急性肾损伤患儿血清miR-452-3p的水平表达及其临床意义[J].现代检验医学杂志,2021,36(06):176.[doi:10.3969/j.issn.1671-7414.2021.06.038]
　HONG Li,ZHENG Qing,CHEN Yong-xiang,et al.Expression and Clinical Significance of Serum miR-452-3p in Children with Sepsis Complicated with Acute Kidney Injury[J].Journal of Modern Laboratory Medicine,2021,36(04):176.[doi:10.3969/j.issn.1671-7414.2021.06.038]
[8]李炳奇,叶俊伟,梅喜平,等.脓毒症患者血液激活素 a，CRP，HMGB1和 vWF表达水平及临床意义[J].现代检验医学杂志,2022,37(01):97.[doi:10.3969/j.issn.1671-7414.2022.01.020]
　LI Bing-qi,YE Jun-wei,MEI Xi-ping,et al.Blood Activator A, CRP, HMGB1 and vWF Expression Levels and Clinical Significance in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2022,37(04):97.[doi:10.3969/j.issn.1671-7414.2022.01.020]
[9]胡　伟,张　涛,盛尚春,等.IGF-1R通过调控JAK/STAT信号通路对脓毒症大鼠作用机制的研究[J].现代检验医学杂志,2022,37(02):6.[doi:10.3969/j.issn.1671-7414.2022.02.002]
　HU Wei,ZHANG Tao,SHENG Shang-chun,et al.Mechanism of IGF-1R on Sepsis Rats by Regulating JAK / STAT Signaling Pathway[J].Journal of Modern Laboratory Medicine,2022,37(04):6.[doi:10.3969/j.issn.1671-7414.2022.02.002]
[10]于大勇a,卢　新b,任平香b,等.老年脓毒症患者血清循环Netrin-1表达水平对发生脑损伤风险的预测价值研究[J].现代检验医学杂志,2022,37(02):76.[doi:10.3969/j.issn.1671-7414.2022.02.016]
　YU Da-yonga,LU Xinb,REN Ping-xiangb,et al.Study on the Value of Serum Circulating Netrin-1 Expression Level in Predicting the Risk of Brain Injury in Elderly Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2022,37(04):76.[doi:10.3969/j.issn.1671-7414.2022.02.016]

备注/Memo

备注/Memo:
基金项目：2018 年省级自然科学基金（青年科技人才专项基金）：BK2018073。
作者简介：孙融（1983-），女，本科，主治医师，研究方向：重症医学，E mail：guanbx1973@163.com。
更新日期/Last Update: 1900-01-01